City

Las Palmas (1)

Madrid (1)

New York (1)

Philadelphia (1)

Condition

Malignant Glioma (1)

Non-Small-Cell-Lung Cancer (NSCLC) (1)

Soft Tissue Sarcoma (1)

Overall Status

Terminated (2)

Active, not recruiting (1)

Phase

n/a (1)

phase 1 (1)

phase 2 (1)

Sponsor

Bernardino Clavo, MD, PhD (1)

Memorial Sloan Kettering Cancer Center (1)

University of Pennsylvania (1)

Collaborator

Fundacion DISA, Canary Islands, Spain (1)

Grupo de Investigacion Clinica en Oncologia Radioterapia (1)

Instituto Canario de Investigacion del Cancer (1)

Instituto Tecnologico Servicios Sanitarios, in MD Anderson Cancer Center, Madrid (1)

Instituto de Salud Carlos III (1)

National Cancer Institute (NCI) (1)

National Institutes of Health (NIH) (1)

RSbiomed (1)

Intervention

18f-fmiso (3)

pet without scs (1)

pet without/with scs (1)

pet/ct (1)

radiotherapy (1)

scs (1)

temozolomide (1)

Study Documents

Intervention Type

drug (3)

device (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

18f-fmiso

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non-Small-Cell-Lung Cancer (NSCLC) Trial in New York (18F-FMISO, PET/CT)

Active, not recruiting

Non-Small-Cell-Lung Cancer (NSCLC)

18F-FMISO
PET/CT

New York, New York

Memorial Sloan Kettering Cancer Center

Jan 3, 2022

Soft Tissue Sarcoma Trial in Philadelphia (18F-FMISO)

Terminated

Soft Tissue Sarcoma

18F-FMISO

Philadelphia, Pennsylvania

University of Pennsylvania

Mar 15, 2021

Malignant Glioma Trial in Las Palmas, Madrid (drug, procedure, device, radiation)

Terminated

Malignant Glioma

18F-FMISO
+5 more

Las Palmas, Spain
+1 more

Aug 23, 2018